| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 92.28B | 87.77B | 83.12B | 86.08B | 77.32B | 68.91B |
| Gross Profit | 21.73B | 20.66B | 18.46B | 15.76B | 13.10B | 12.73B |
| EBITDA | 17.72B | 16.78B | 14.61B | 12.50B | 10.12B | 10.01B |
| Net Income | 10.78B | 10.18B | 9.25B | 8.20B | 5.32B | 5.38B |
Balance Sheet | ||||||
| Total Assets | 130.51B | 125.23B | 120.36B | 105.03B | 103.61B | 97.96B |
| Cash, Cash Equivalents and Short-Term Investments | 44.62B | 44.16B | 41.66B | 38.72B | 36.95B | 36.39B |
| Total Debt | 169.00M | 921.00M | 675.00M | 552.00M | 617.00M | 877.00M |
| Total Liabilities | 37.36B | 34.69B | 35.62B | 33.52B | 35.03B | 29.37B |
| Stockholders Equity | 91.16B | 88.58B | 82.98B | 69.88B | 67.03B | 67.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.53B | 5.34B | 7.41B | 7.51B | 6.67B |
| Operating Cash Flow | 0.00 | 13.37B | 8.69B | 9.76B | 9.30B | 8.90B |
| Investing Cash Flow | 0.00 | -5.35B | -3.83B | -7.01B | -2.16B | -2.82B |
| Financing Cash Flow | 0.00 | -5.62B | -2.24B | -1.24B | -6.79B | -1.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥37.65B | 7.75 | ― | 3.59% | 6.91% | 13.17% | |
77 Outperform | ¥48.00B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
75 Outperform | ¥101.11B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
66 Neutral | ¥108.93B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥129.11B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
64 Neutral | ¥64.64B | 20.20 | ― | 1.49% | -8.92% | 1.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |